Danese S - Search Results

1

The safety of vedolizumab for ulcerative colitis and Crohn's disease.

Colombel JF, Sands BE, Rutgeerts P, Sandborn W, Danese S, D'Haens G, Panaccione R, Loftus EV Jr, Sankoh S, Fox I, Parikh A, Milch C, Abhyankar B, Feagan BG. Colombel JF, et al. Among authors: danese s. Gut. 2017 May;66(5):839-851. doi: 10.1136/gutjnl-2015-311079. Epub 2016 Feb 18. Gut. 2017. PMID: 26893500 Free PMC article.

2

Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Sturm A, Leite AZ, Danese S, Krivacic KA, West GA, Mohr S, Jacobberger JW, Fiocchi C. Sturm A, et al. Among authors: danese s. Gut. 2004 Nov;53(11):1624-31. doi: 10.1136/gut.2003.033613. Gut. 2004. PMID: 15479683 Free PMC article.

3

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Danese S, Sans M, Spencer DM, Beck I, Doñate F, Plunkett ML, de la Motte C, Redline R, Shaw DE, Levine AD, Mazar AP, Fiocchi C. Danese S, et al. Gut. 2007 Jun;56(6):855-62. doi: 10.1136/gut.2006.114314. Epub 2006 Dec 14. Gut. 2007. PMID: 17170016 Free PMC article.

4

Biological agents for ulcerative colitis: hypes and hopes.

Danese S, Angelucci E, Malesci A, Caprilli R. Danese S, et al. Med Res Rev. 2008 Mar;28(2):201-18. doi: 10.1002/med.20103. Med Res Rev. 2008. PMID: 17464967 Review.

5

Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance.

Danese S, Pagano N, Angelucci E, Stefanelli T, Repici A, Omodei P, Daperno M, Malesci A. Danese S, et al. Curr Med Chem. 2007;14(14):1489-97. doi: 10.2174/092986707780831104. Curr Med Chem. 2007. PMID: 17584058 Review.

6

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.

Danese S. Danese S. Dig Liver Dis. 2008 Jul;40 Suppl 2:S225-8. doi: 10.1016/S1590-8658(08)60530-7. Dig Liver Dis. 2008. PMID: 18598993

7

The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.

Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A, Mantovani A, Locati M, Danese S. Vetrano S, et al. Among authors: danese s. Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20. Gut. 2010. PMID: 19846409

8

Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases.

Danese S, Gao B. Danese S, et al. Gut. 2010 Feb;59(2):149-51. doi: 10.1136/gut.2008.173534. Gut. 2010. PMID: 20176636 Free PMC article. No abstract available.

9

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

Fiorino G, Rovida S, Correale C, Malesci A, Danese S. Fiorino G, et al. Among authors: danese s. Curr Drug Targets. 2010 Feb;11(2):249-60. doi: 10.2174/138945010790309975. Curr Drug Targets. 2010. PMID: 20210771 Review.

10

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP; European Crohn's and Colitis Organisation (ECCO). Dignass A, et al. Among authors: danese s. J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15. J Crohns Colitis. 2010. PMID: 21122489 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,188 results

Search Page

Filters